Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-10

Clinical Trial Update: The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants [Phase 3]

View source ↗

Summary

Phase 3 trial update for the PEBBLES study evaluating a preventive strategy for eczema and food allergy in high-risk infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Melbourne | Conditions: Eczema, Asthma | Phase 3 | Status: ACTIVE_NOT_RECRUITING